FDA Drug Application (021342) for LEVO-T by ALARA PHARM

Back to FDA Applications sponsored by ALARA PHARM

Application Number021342
Product Number001
FormTABLET;ORAL
Dosage0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB1,AB2,AB3 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLEVO-T
Active IngredientLEVOTHYROXINE SODIUM

Active IngredientCount
List of drugs with Active Ingredient LEVOTHYROXINE SODIUM9


Back to FDA Applications sponsored by ALARA PHARM